Skip to contentSkip to content
Verified credentials. On-chain. Forever.Learn more
Ewance
Sign in
Cover image for Hostile Takeover Defense for a Mid-Cap Pharma Firm
Strategy

Hostile Takeover Defense for a Mid-Cap Pharma Firm

FreeVerified credential1 weekExpert

Overview

What this challenge is about.

You will analyze a hostile takeover bid for a mid-cap pharma firm, assess its intrinsic value, and recommend a defense strategy. Get a verifiable certificate.

The scenario

MediCore has a market cap of €1.5B, with a promising Phase 3 drug for Alzheimer's. PharmaGiant offered €1.8B in cash, but MediCore's independent valuation suggests €2.5B. The bid is financed through debt.

CredentialBlockchain-anchored
ShareableLinkedIn-ready
LanguageEnglish
PaceSelf-paced

The Brief

What you'll do, and what you'll demonstrate.

How can MediCore defend against the hostile takeover and secure a better outcome for shareholders?

Earning criteria — what you'll demonstrate

  • Evaluate the adequacy of a takeover bid using multiple valuation methods
  • Design a comprehensive defense strategy including legal and financial tactics
  • Identify and approach potential white knights
  • Manage shareholder and regulatory communications during a hostile bid

Program Fit

Where this fits in your program.

Sharpens the same skills your degree expects you to demonstrate.

Aligned coursework coming soon.

One more thing

You can put a credential on your CV by Friday.